Home › Drug Codes › J Codes › J9271 · KEYTRUDA
Updated July 1st, 2026

KEYTRUDA J Code: J9271

Injection, pembrolizumab, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9271, effective October 1, 2026: $62.253 per HCPCS billing unit, up 2.7% from $60.645. From CMS's final file.

?
Medicare Payment Limit ?
$60.645
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$60.645
/ HCPCS billing unit · APC 1490
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, pembrolizumab, 1 mg
HCPCS Added Date January 1, 2016
Manufacturer Merck Sharp & Dohme Corp
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About KEYTRUDA

Keytruda is a medication aligned to the HCPCS J Code: J9271 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Merck Sharp & Dohme Corp.

According to CMS Drug Use Information: Pembrolizumab is used to treat cancer. It works by changing how your immune system works, making it attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00006-3026-02 Keytruda Merck Sharp & Dohme LLC 100 100 MG / 4 ML
00006-3026-04 Keytruda Merck Sharp & Dohme LLC 200 100 MG / 4 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

KEYTRUDA Pricing & Reimbursement

J9271 Private Payer Reimbursement
$61.95 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

KEYTRUDA Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 10.68%
Avg. Days to File 7.9days
Avg. Days to Pay 25.1days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9271 claims analytics on FocalPoint →
OnPoint Oncology

KEYTRUDA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Keytruda (J9271) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

KEYTRUDA Medically Unlikely Edits (MUE)

The most billing units of J9271 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
400 units / day
= 400 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

KEYTRUDA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Biliary Tract Cancer Cervical Cancer Classical Hodgkin Lymphoma Cutaneous Squamous Cell Carcinoma Endometrial Carcinoma Esophageal Cancer Gastric Cancer Head and Neck Squamous Cell Cancer Hepatocellular Carcinoma MSI-H or dMMR Cancer MSI-H or dMMR Colorectal Cancer Malignant Pleural Mesothelioma Melanoma Merkel Cell Carcinoma Muscle Invasive Bladder Cancer Non-Muscle Invasive Bladder Cancer Non-Small Cell Lung Cancer Ovarian Cancer Primary Mediastinal Large B-Cell Lymphoma Renal Cell Carcinoma Triple-Negative Breast Cancer Tumor Mutational Burden-High Cancer Urothelial Cancer Urothelial Carcinoma
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Keytruda billing and coding guide?
Billing and coding information for KEYTRUDA can be found through Merck. Visit Here →
Are there any available Keytruda patient assistance programs?
KEYTRUDA patient assistance information can be found through Merck Sharp & Dohme Corp. Visit Here →
Where can I find Keytruda prescribing information?
KEYTRUDA prescribing information can be found at the link below: Visit Here →
Where can I find Keytruda side effect information?
Information regarding KEYTRUDA's side effects can be found at MedlinePlus Visit Here →
Does billing KEYTRUDA require JZ/JW wastage modifiers?
CMS has identified KEYTRUDA(J9271) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.